Goserelin--depot preparation of LHRH analogue used in the treatment of endometriosis.

R W Shaw, Shaw RW
Progress in clinical and biological research · 1990 · vol. 323 , pp. 383–92 · PMID:2137621 · W2412779394
article OA: closed CC0 ⤵ 5 in-corpus citations
View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

Monthly subcutaneous goserelin depot injections for six months effectively desensitized the pituitary, induced hypo-oestrogenism, and relieved endometriosis symptoms by reducing disease deposits.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

In summary then, Zoladex depot (Goserelin 3.6 mg) administered monthly for a period of six months proved highly efficacious in achieving endocrine parameters of pituitary desensitization and hypo-oestrogenism. Initial studies treating symptomatic patients with endometriosis shows satisfactory relief of symptoms and significant impact on the disease process as shown by resolution or reduction in number and size of disease deposits. The depot can be given as a subcutaneous injection without the need of local anaesthesia and its duration of action is 28 days. Zoladex depot should offer a suitable, acceptable form of treatment for patients with endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Buserelin Endometriosis Buserelin Buserelin Buserelin Buserelin Chemistry, Pharmaceutical Delayed-Action Preparations Endocrine Glands Endocrine Glands Endocrine Glands Endometriosis Endometriosis Female Goserelin Humans Multicenter Studies as Topic Safety

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (5)

Source provenance

europepmc
last seen: 2026-08-10T06:11:17.106188+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:12:15.619952+00:00
License: CC0 · commercial use OK